The Moscow Endocrine Plant considers the possibility of cooperation with partners who have modern technologies of the production of various types of active pharmaceutical ingredients from raw materials of animal origin, plant origin, obtained by biotechnological and chemical synthesis.
The commissioning of a modern enterprise for the production of active pharmaceutical ingredients and the subsequent production of drugs from them at the production sites of the Moscow Endocrine Plant will enable it to profit from the sale of drugs at the Russian and foreign markets together with partners.
The advantages of the production complex in the Bryansk region:
- Availability of the property complex;
- Availability of developed infrastructure, including utilities and communications;
- Availability of a sufficient volume of energy resources: electricity, water, natural gas, compressed air, nitrogen;
- Availability of a facility security system, the technical level of equipment fully complies with the requirements of the legislation of the Russian Federation;
- Availability of transport and warehouse infrastructure.
Comment type is not specified in the component properties.